Semen Baturaja (Persero) Tbk PT
IDX:SMBR
Semen Baturaja (Persero) Tbk PT
IDX:SMBR
Price:
202
IDR
-2.88%
Market Closed
Market Cap:
2T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SMBR Alert
Semen Baturaja (Persero) Tbk PT
202
-6 (-2.88%)
| 52 Week Range |
200
288
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Semen Baturaja (Persero) Tbk PT
Balance Sheet
Balance Sheet Decomposition
Semen Baturaja (Persero) Tbk PT
Semen Baturaja (Persero) Tbk PT
| Current Assets | 786.8B |
| Cash & Short-Term Investments | 29.8B |
| Receivables | 455.7B |
| Other Current Assets | 301.4B |
| Non-Current Assets | 3.9T |
| Long-Term Investments | 25m |
| PP&E | 3.9T |
| Intangibles | 9.9B |
| Other Non-Current Assets | 84.5B |
| Current Liabilities | 662.2B |
| Accounts Payable | 414.4B |
| Accrued Liabilities | 59.6B |
| Other Current Liabilities | 188.3B |
| Non-Current Liabilities | 901.2B |
| Long-Term Debt | 627.2B |
| Other Non-Current Liabilities | 273.9B |
Balance Sheet
Semen Baturaja (Persero) Tbk PT
Semen Baturaja (Persero) Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
69 374
|
81 810
|
82 356
|
136 736
|
150 317
|
93 454
|
124 469
|
484 704
|
522 918
|
98 387
|
|
| Cash |
73 924
|
586 360
|
86 979
|
121 386
|
164 827
|
114 649
|
124 469
|
74 704
|
77 918
|
8 387
|
|
| Cash Equivalents |
4 550
|
504 550
|
4 623
|
15 350
|
14 510
|
21 194
|
0
|
410 000
|
445 000
|
90 000
|
|
| Short-Term Investments |
1 984 550
|
1 169 550
|
254 623
|
349 650
|
315 510
|
92 194
|
238 000
|
551
|
445 377
|
0
|
|
| Total Receivables |
86 718
|
40 660
|
212 788
|
408 276
|
489 675
|
484 660
|
459 093
|
182 827
|
207 728
|
463 078
|
|
| Accounts Receivables |
86 718
|
40 660
|
212 788
|
408 276
|
488 193
|
481 591
|
450 748
|
182 208
|
204 537
|
458 969
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1 482
|
3 070
|
8 345
|
618
|
3 190
|
4 109
|
|
| Inventory |
187 421
|
185 853
|
174 238
|
203 192
|
291 077
|
340 862
|
249 819
|
233 054
|
226 320
|
245 900
|
|
| Other Current Assets |
7 705
|
460 693
|
114 227
|
25 749
|
111 751
|
60 812
|
30 276
|
18 723
|
33 330
|
9 481
|
|
| Total Current Assets |
2 335 769
|
1 938 567
|
838 232
|
1 123 602
|
1 358 330
|
1 071 983
|
1 101 657
|
919 859
|
990 295
|
816 846
|
|
| PP&E Net |
557 907
|
787 024
|
3 480 075
|
3 844 488
|
4 012 559
|
4 171 967
|
4 242 524
|
4 118 811
|
4 081 841
|
3 955 399
|
|
| PP&E Gross |
557 907
|
787 024
|
3 480 075
|
3 844 488
|
4 012 559
|
4 171 967
|
4 242 524
|
4 118 811
|
4 081 841
|
3 955 399
|
|
| Accumulated Depreciation |
644 631
|
735 667
|
826 503
|
975 628
|
1 121 664
|
1 252 786
|
1 413 068
|
1 581 893
|
1 756 290
|
1 971 693
|
|
| Intangible Assets |
3 329
|
3 383
|
3 282
|
18 342
|
78 507
|
176 912
|
241 077
|
27 897
|
20 186
|
12 194
|
|
| Long-Term Investments |
5 288
|
5 288
|
5 512
|
17 753
|
17 778
|
17 778
|
17 778
|
25
|
25
|
25
|
|
| Other Long-Term Assets |
26 188
|
534 407
|
41 775
|
56 152
|
70 906
|
132 631
|
134 139
|
205 363
|
150 377
|
72 267
|
|
| Total Assets |
2 928 480
N/A
|
3 268 668
+12%
|
4 368 877
+34%
|
5 060 337
+16%
|
5 538 080
+9%
|
5 571 270
+1%
|
5 737 176
+3%
|
5 271 954
-8%
|
5 242 725
-1%
|
4 856 731
-7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
91 259
|
109 968
|
153 672
|
232 464
|
461 979
|
300 135
|
258 776
|
247 355
|
311 227
|
417 359
|
|
| Accrued Liabilities |
59 505
|
81 109
|
99 679
|
105 290
|
54 217
|
37 476
|
98 486
|
44 277
|
81 562
|
53 302
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
15 619
|
0
|
59 241
|
103 684
|
465 410
|
71 752
|
102 512
|
184 320
|
|
| Other Current Liabilities |
28 985
|
43 617
|
23 268
|
331 074
|
60 971
|
27 232
|
27 467
|
63 271
|
92 838
|
76 513
|
|
| Total Current Liabilities |
179 749
|
234 694
|
292 238
|
668 828
|
636 408
|
468 526
|
850 139
|
426 655
|
588 139
|
731 493
|
|
| Long-Term Debt |
0
|
0
|
624 678
|
935 517
|
1 329 776
|
1 464 932
|
1 262 557
|
1 670 808
|
1 374 652
|
707 436
|
|
| Deferred Income Tax |
0
|
0
|
24
|
0
|
54 319
|
109 724
|
126 760
|
75 741
|
93 555
|
128 019
|
|
| Minority Interest |
0
|
0
|
29
|
34
|
36
|
38
|
35
|
15
|
25
|
23
|
|
| Other Liabilities |
65 639
|
84 622
|
331 180
|
43 132
|
43 906
|
45 794
|
89 831
|
98 584
|
111 241
|
127 370
|
|
| Total Liabilities |
245 389
N/A
|
319 315
+30%
|
1 248 148
+291%
|
1 647 511
+32%
|
2 064 445
+25%
|
2 089 015
+1%
|
2 329 322
+12%
|
2 271 773
-2%
|
2 167 562
-5%
|
1 694 295
-22%
|
|
| Equity | |||||||||||
| Common Stock |
983 768
|
983 768
|
983 768
|
992 480
|
993 253
|
993 253
|
993 253
|
993 253
|
993 253
|
993 253
|
|
| Retained Earnings |
707 066
|
979 162
|
1 135 542
|
1 217 417
|
1 256 828
|
1 267 929
|
1 203 320
|
790 703
|
873 858
|
976 463
|
|
| Additional Paid In Capital |
1 034 032
|
1 034 032
|
1 034 032
|
1 247 473
|
1 270 607
|
1 270 607
|
1 270 607
|
1 270 607
|
1 270 607
|
1 270 607
|
|
| Other Equity |
41 774
|
47 609
|
32 613
|
44 544
|
47 054
|
49 534
|
59 326
|
54 382
|
62 555
|
77 888
|
|
| Total Equity |
2 683 092
N/A
|
2 949 353
+10%
|
3 120 729
+6%
|
3 412 826
+9%
|
3 473 635
+2%
|
3 482 255
+0%
|
3 407 854
-2%
|
3 000 181
-12%
|
3 075 163
+2%
|
3 162 436
+3%
|
|
| Total Liabilities & Equity |
2 928 480
N/A
|
3 268 668
+12%
|
4 368 877
+34%
|
5 060 337
+16%
|
5 538 080
+9%
|
5 571 270
+1%
|
5 737 176
+3%
|
5 271 954
-8%
|
5 242 725
-1%
|
4 856 731
-7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
9 838
|
9 838
|
9 838
|
9 925
|
9 933
|
9 933
|
9 933
|
9 933
|
9 933
|
9 933
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
